Literature DB >> 17881454

Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant.

Artur Kaul1, Ilka Woerz, Philip Meuleman, Geert Leroux-Roels, Ralf Bartenschlager.   

Abstract

Production of infectious hepatitis C virus in cell culture has become possible because of the unique properties of the JFH1 isolate. However, virus titers are rather low, limiting the utility of this system. Here we describe the generation of cell culture-adapted JFH1 variants yielding higher titers of infectious particles and enhanced spread of infection in cultured cells. Sequence analysis of adapted genomes revealed a complex pattern of mutations that differed in two independent experiments. Adaptive mutations were observed both in the structural and in the nonstructural regions, with the latter having the highest impact on enhancement of virus titers. The major adaptive mutation was identified in NS5A, and it enhanced titers of three intergenotypic chimeras consisting of the structural region of a genotype 1a, 1b, or 3a isolate and the remainder of the JFH1 isolate. The mutation resides at the P3 position of the NS5A-B cleavage site and slows down processing, implying that subtle differences in replication complex formation appear to determine the efficiency of virus formation. Highly adapted JFH1 viruses carrying six mutations established a robust infection in uPA-transgenic SCID mice xenografted with human hepatocytes. However, the mutation in NS5A which enhanced virus titers in cell culture the most had reverted to wild type in nearly half of the viral genomes isolated from these animals at 15 weeks postinoculation. These results argue for some level of impaired fitness of this mutant in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881454      PMCID: PMC2169131          DOI: 10.1128/JVI.01362-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro.

Authors:  Dean Clarke; Stephen Griffin; Lucy Beales; Corine St Gelais; Stan Burgess; Mark Harris; David Rowlands
Journal:  J Biol Chem       Date:  2006-10-10       Impact factor: 5.157

2.  Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles.

Authors:  Pablo Gastaminza; Sharookh B Kapadia; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

3.  Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses.

Authors:  George Koutsoudakis; Artur Kaul; Eike Steinmann; Stephanie Kallis; Volker Lohmann; Thomas Pietschmann; Ralf Bartenschlager
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

5.  The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.

Authors:  George Koutsoudakis; Eva Herrmann; Stephanie Kallis; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus.

Authors:  MinKyung Yi; Yinghong Ma; Jeremy Yates; Stanley M Lemon
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

7.  Persistent hepatitis C virus infection in vitro: coevolution of virus and host.

Authors:  Jin Zhong; Pablo Gastaminza; Josan Chung; Zania Stamataki; Masanori Isogawa; Guofeng Cheng; Jane A McKeating; Francis V Chisari
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

8.  Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein.

Authors:  P Neddermann; A Clementi; R De Francesco
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

9.  euHCVdb: the European hepatitis C virus database.

Authors:  Christophe Combet; Nicolas Garnier; Céline Charavay; Delphine Grando; Daniel Crisan; Julien Lopez; Alexandre Dehne-Garcia; Christophe Geourjon; Emmanuel Bettler; Chantal Hulo; Philippe Le Mercier; Ralf Bartenschlager; Helmut Diepolder; Darius Moradpour; Jean-Michel Pawlotsky; Charles M Rice; Christian Trépo; François Penin; Gilbert Deléage
Journal:  Nucleic Acids Res       Date:  2006-11-16       Impact factor: 16.971

10.  Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras.

Authors:  Marco Binder; Doris Quinkert; Olga Bochkarova; Rahel Klein; Nikolina Kezmic; Ralf Bartenschlager; Volker Lohmann
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

View more
  86 in total

1.  New horizons for studying human hepatotropic infections.

Authors:  Ype P de Jong; Charles M Rice; Alexander Ploss
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  The entire core protein of HCV JFH1 is required for efficient formation of infectious JFH1 pseudoparticles.

Authors:  Priyanka Shukla; Kristina N Faulk; Suzanne U Emerson
Journal:  J Med Virol       Date:  2010-05       Impact factor: 2.327

3.  Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.

Authors:  Maria V Pokrovskii; Caroline O Bush; Rudolf K F Beran; Margaret F Robinson; Guofeng Cheng; Neeraj Tirunagari; Martijn Fenaux; Andrew E Greenstein; Weidong Zhong; William E Delaney; Matthew S Paulson
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.

Authors:  Adam Zuiani; Kevin Chen; Megan C Schwarz; James P White; Vincent C Luca; Daved H Fremont; David Wang; Matthew J Evans; Michael S Diamond
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

5.  Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.

Authors:  Andreas Merz; Gang Long; Marie-Sophie Hiet; Britta Brügger; Petr Chlanda; Patrice Andre; Felix Wieland; Jacomine Krijnse-Locker; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

Review 6.  Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

Authors:  Da-Rong Yang; Hai-Zhen Zhu
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

Review 7.  Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.

Authors:  Troels K H Scheel; Charles M Rice
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

8.  NS2 proteins of GB virus B and hepatitis C virus share common protease activities and membrane topologies.

Authors:  Célia Boukadida; Caroline Marnata; Roland Montserret; Lisette Cohen; Brigitte Blumen; Jérôme Gouttenoire; Darius Moradpour; François Penin; Annette Martin
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

9.  Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.

Authors:  Artur Kaul; Sarah Stauffer; Carola Berger; Thomas Pertel; Jennifer Schmitt; Stephanie Kallis; Margarita Zayas; Margarita Zayas Lopez; Volker Lohmann; Jeremy Luban; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

10.  Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation.

Authors:  MinKyung Yi; Yinghong Ma; Jeremy Yates; Stanley M Lemon
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.